DiaSorin Company Research & Development Immunodiagnostic Solutions Molecular Solutions People Culture Investor Relations Social Responsibility Hypertension 1 billion people worldwide have high blood pressure and this number is expected to increase to 1.56 billion people by the year 2025. This translates to around 1 in 4 adults being afflicted by hypertension as stated by World Hypertension Organizations. Hypertension is prevalent in developing as well as in developed countries. According to recent estimates of CDC, 67 million Americans have hypertension and half of these do not have it adequately controlled. Nearly 1 in 3 U.S. adults have high blood pressure, but approximately 1/3 of these are undiagnosed due to the asymptomatic nature of hypertension. In fact, many people have high blood pressure for years without knowing it. American Heart Association as well as WHO have reported that Hypertension is long been recognized as a major risk factor for cardiovascular disease. Renin and Aldosterone Immunodiagnostic Solutions Clinical Areas Infectious Diseases Bone and Mineral Endocrinology Hypertension Renin and Aldosterone Oncology Stool Diagnostics Autoimmunity Cardiac and Brain Damages Systems Committed to efficiency News Events Catalog Dialog Contacts Search form Search English Italiano DiaSorin S.p.A. - Share Capital € 55.948.257 R.E.A. 180729 Fiscal Code and Subscription to Vercelli Companies Register no 13144290155 Legal Notices Privacy Policy Modern Slavery Act Statement Scroll down ▼ close Android Iphone INTERNATIONAL USA Disclaimer: the DIASORIN site content linked here is for outside the United States only. Continue to our International Section Disclaimer: the DIASORIN site content linked here is for United States only. Continue to our US Section Ai sensi delle Linee Guida del Ministero della Salute del 28/03/2013, relative alla pubblicità sanitaria concernente i dispositivi medici, dispositivi medico-diagnostici in vitro e presidi medico-chirurgici, si avvisa l'utente che le informazioni contenute nel presente sito Internet e alle quali si sta per accedere sono esclusivamente rivolte agli operatori professionali Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professional operators